Alzheimer | Tokio X'press

Selling price for Lecanemab: $26,500 per patient per year!

Saturday January 14th, 2023By Tokio X'press Alzheimer, FDA, Medical science, Pharmaceutical

Eisai: Suppresses exacerbation of Alzheimer’s symptoms！

Tuesday December 6th, 2022By Tokio X'press Alzheimer, Drugs, Medical science, Pharmaceutical

Eisai: New drug for Alzheimer’s disease!

Sunday October 16th, 2022By Tokio X'press Alzheimer, disease, Medical science, Pharmaceutical

Keio University: Creating brain organoids with iPS!

Friday September 16th, 2022By Tokio X'press Alzheimer, IPS, Medical science

iPS drug discovery: Discover drugs that reduce amyloid beta!

Thursday July 7th, 2022By Tokio X'press Alzheimer, hospital, Drugs, disease, IPS, Medical science

1 2 … 4